[1. Vardiman JW, Brunning RD, Arber DA, Lebean MM, Porurt A, Telferi A, et al. Introduction and Overview of the Classification of the Myeloid Neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. IARC, Lyon. 2008;18-49.]Search in Google Scholar
[2. Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med. 2006 Dec;355(23):2452-66. DOI: 10.1056/NEJMra06372810.1056/NEJMra06372817151367]Search in Google Scholar
[3. Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc HematolEduc Program. 2012 Dec;2012(1):571-81.10.1182/asheducation.V2012.1.571.3798557]Search in Google Scholar
[4. Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis.Blood. 2013 Mar;122(13):2176-84. DOI: 10.1182/blood-2013-03-46015410.1182/blood-2013-03-46015423823316]Search in Google Scholar
[5. Landolfi R, Di Gennaro I, Falanga A. Thrombosis in myeloproliferative disorders: pathogenic facts and speculation. Leukemia. 2008 Nov;22(11):2020-8. DOI: 10.1038/leu.2008.25310.1038/leu.2008.25318800144]Search in Google Scholar
[6. Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Villamor N, Colomer D, Cervantes F. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with JAK2 mutation status. Haematologica. 2006 Feb;91(2):169-75.]Search in Google Scholar
[7. Panova-Noeva M, Marchetti M, Russo L, Tartari CJ, Leuzzi A, Finazzi G, et al. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera. Thromb Res. 2013 Jul;132(1):88-93. DOI: 10.1016/j. thromres.2013.05.003]Search in Google Scholar
[8. Machin SJ, Briggs C. Mean platelet volume: a quick, easy determinant of thrombotic risk? J Thromb Haemost. 2010 Jan;8(1);146-7. DOI: 10.1111/j.1538-7836.2009.03673.x10.1111/j.1538-7836.2009.03673.x19874471]Search in Google Scholar
[9. Demirin H, Ozhan H, Ucgun T, Celer A, Bulur S, Cil H, et al. Normal range of mean platelet volume in healthy subjects: Insight from a large epidemiologic study. Thromb Res. 2011 Oct;128(4):358-60. DOI: 10.1016/j. thromres.2011.05.007]Search in Google Scholar
[10. Riedl J, Pabinger I, Ay C. Platelets in cancer and thrombosis. Hämostaseologie. 2014 Feb;34(1):54-62. DOI: 10.5482/HAMO-13-10-005410.5482/HAMO-13-10-005424305775]Search in Google Scholar
[11. Leader A, Pereg D, Lishner M. Are platelet indices of clinical use? A multidisciplinary review. Ann Med. 2012 Dec;44(8):805-16. DOI: 10.3109/07853890.2011.65339110.3109/07853890.2011.65339122413913]Search in Google Scholar
[12. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta- analysis. J Thromb Haemost. 2010 Jan;8(1):148-56. DOI: 10.1111/j.1538-7836.2009.03584.x10.1111/j.1538-7836.2009.03584.x375549619691485]Search in Google Scholar
[13. Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost. 2011 Jan;9(1):49-56. DOI: 10.1111/j.1538-7836.2010.04110.x10.1111/j.1538-7836.2010.04110.x20942852]Search in Google Scholar
[14. Muscari A, Puddu GM, Cenni A, Silvestri MG, Giuzio R, Rosati M, et al. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb Res. 2009 Feb; 123(4):587-91. DOI: 10.1016/j. thromres.2008.03.025]Search in Google Scholar
[15. Brækkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost. 2010 Jan;8(1):157-62. DOI: 10.1111/j.1538-7836.2009.03498.x10.1111/j.1538-7836.2009.03498.x19496920]Search in Google Scholar
[16. Gohda F, Uchiumi H, Handa H, Matsushima T, Tsukamoto N, Morita K, et al. Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia. Thromb Res. 2007;119(6):741-6. DOI: 10.1016/j.thromres.2006.06.01110.1016/j.thromres.2006.06.01116916536]Search in Google Scholar
[17. Thiele J, Imbert M, Pierre R, Vardiman JW, Brunning RD, Flandrin G. Chronic idiopathic myelofibrosis. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:35-38.]Search in Google Scholar
[18. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 2005 Sep;106 (6):2162-68. DOI: 10.1182/ blood-2005-03-132010.1182/blood-2005-03-132015920007]Search in Google Scholar
[19. Lippi G, Meschi T, Borghi L. Mean platelet volume increases with aging in a large population study. Thromb Res. 2012 Apr;129(4):e159-60. DOI: 10.1016/j.thromres. 2011.12.031]Search in Google Scholar
[20. Zhang J, Huang W. Reference range of mean platelet volume in Chinese individuals. Thromb Res. 2014 Mar;133(3):517-8. DOI: 10.1016/j.thromres. 2013.12.011]Search in Google Scholar
[21. Cho SY, Lee HJ, Lee WI, Suh JT, Park TS. Large population study for the reference range of mean platelet volume in Korean individuals. Thromb Res. 2012 Sep;130(3):557-8. DOI: 10.1016/j.thromres. 2012.05.009]Search in Google Scholar
[22. Meisinger C, Prokisch H, Gieger C, Soranzo N, Mehta D, Rosskopf D, et al. A genome-wide association study indentifies three loci associated with mean platelet volume. Am J Hum Genet. 2009 Jan;84(1);66-71. DOI: 10.1016/j.ajhg.2008.11.01510.1016/j.ajhg.2008.11.015266803619110211]Search in Google Scholar
[23. Lancé MD, van Oerle R, Henskens YM, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol. 2010 Sep;16(3):28-31. DOI: 10.1532/LH96.1001110.1532/LH96.1001120858586]Search in Google Scholar
[24. Vinholt JP, Hvas AM, Nybo M. An overview of platelet indices and methods for evaluation platelet function in thrombocytopenic patients. Eur J Haematol. 2014 Jun;92(5):367-76. DOI: 10.1111/ejh.1226210.1111/ejh.1226224400878]Search in Google Scholar
[25. Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Villamor N, Jou JM, Cervantes F. Automated assessment of the neutrophil and platelet activation status in patients with essential thrombocythemia. Platelets. 2012 Aug;23(5):336-43. DOI: 10.3109/09537104.2011.63011210.3109/09537104.2011.63011222059534]Search in Google Scholar
[26. Riedl J, Kaider A, Reitter EM, Marosi C, Jäger U, Schwarzinger I, et al. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Thromb Haemost. 2014 Apr;111(4):670-8. DOI: 10.1160/TH13-07-060310.1160/TH13-07-060324306221]Search in Google Scholar
[27. Latger-Cannard V, Hoarau M, Salignac S, Baumgart P, Lecompte T, Nurden P. Mean platelet volume: comparison of three analysers towards standardization of platelet morphological phenotype. Int Jnl Lab Hem. 2012 Jun;34(3):300-10. DOI: 10.1111/j.1751-553X.2011.01396.x10.1111/j.1751-553X.2011.01396.x22225539]Search in Google Scholar
[28. Colita A, Butoianu E, Nicoara S. Boli clonale ale celulelor stem hematopoietice. In: Paun R. Tratat de Me dicina Interna, Hematologie, partea aIIa,Editura Medicala, Bucuresti. 1999;164-84.]Search in Google Scholar
[29. Bain BJ, Disorders of red cells and platelets. In: Blood cells: A Practical Guide. 4th edition. Blackwell Publishing, Carlton, Victoria. 2006;283-97. DOI: 10.1002/9780470987551. ch8 DOI: 10.1002/9780470987551 DOI: 10.1002/9780470987551.ch910.1002/9780470987551]Search in Google Scholar
[30. Shah B, Valdes V, Nardi MA, Hu L, Schrem E, Berger IS. Mean platelet volume reproductibility and association with platelet activity and anti-platelet therapy. Platelets. 2014;25(3):188-92. DOI: 10.3109/09537104.2013.79379410.3109/09537104.2013.793794380902123786366]Search in Google Scholar
[31. Panova-Noeva M, Marcetti M, Buoro S, Russo L, Leuzzi A, Finazzi G, et al.Jak2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients. Blood. 2011 Sep;118(9):2599-601. DOI: 10.1182/blood-2011-02-33965510.1182/blood-2011-02-33965521750318]Search in Google Scholar
[32. Bellucci S, Legrand C, Boval B, Drouet L, Caen J. Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide. Brit J Haematol 1999;104:886-892. DOI: 10.1046/j.1365-2141.1999.01234.x10.1046/j.1365-2141.1999.01234.x10192455]Search in Google Scholar
[33. Coban E, Afacan B. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hipolipidemic diet treatment. Platelets. 2008 Mar;19(2):111-4. DOI: 10.1080/0953710070123044410.1080/0953710070123044417852772]Search in Google Scholar
[34. Carobbio A, Finazzi G, Anatonioli E, Guglielmelli P, Vannucchi AM, Dellacasa CM, et al. JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera. Exp Hematol. 2009 Sep;37(9):1016-21. DOI: 10.1016/j. exphem.2009.06.006]Search in Google Scholar
[35. Falanga A, Marchetti M, Vignoli A, Balducci D, Russo L, Guerini V, et al. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules. Exp Hematol. 2007 May;35(5):702-11. DOI: 10.1016/j.exphem.2007.01.053 10.1016/j.exphem.2007.01.05317577920]Search in Google Scholar